DendroTEK Biosciences Inc. jobs and careers

About DendroTEK Biosciences Inc.

DendroTEK Biosciences develops defined surface chemistries and matrices that make cell culture more reproducible and scalable. Our flagship technology, dPGA (dendritic polyglycerol amine), is a next-generation coating that promotes robust cellular adhesion and neural readouts compared with conventional poly-L/D-lysine—supporting long-term iPSC-derived cell culture, MEA assays, and disease-model workflows. What we offer – Cellular coatings (dPGA): Consistent attachment and healthy morphology to enable reliable synaptic and functional endpoints (e.g., MEA, imaging). – Synthetic matrix (in development): A defined alternative to tissue extracts for stem cell maintenance, differentiation, organoids, and coculture. – Application support: Practical protocols, QC guidance, and integration with electrophysiology/imaging platforms for translational neuroscience. Who we serve – Academic and core labs building iPSC-derived neural models and organoids – Biotech and pharma teams running phenotypic screening or target validation – Instrument and MEA providers seeking reproducible cell-based performance Our collaboration network includes leading academic groups; DendroTEK is a company partner in a CQDM/Brain Canada–supported project led by Prof. Timothy E. Kennedy (McGill University) to deliver a next-generation synthetic matrix for stem-cell and neurodegeneration research. We believe better surfaces and matrices shorten the path from cell culture to actionable data—accelerating neuroscience and neurotherapeutic discovery. Learn more at dendrotek.ca or message us here to discuss evaluations, collaborations, and distribution. For Research Use Only. Not for diagnostic or therapeutic use.